NCT04180033View on ClinicalTrials.gov

Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy

NACompletedINTERVENTIONAL

Enrollment

154

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

November 25, 2022

Study Completion Date

November 25, 2022

Conditions

Testicular CancerColorectal Neoplasms

Interventions

DIAGNOSTIC_TEST

Colonoscopy surveillance

Participants will be asked to undergo a first colonoscopy surveillance.

Trial Locations (4)

6500 HB

Radboud University Medical Center, Nijmegen

3000 CA

Erasmus Medical Center, Rotterdam

1066CX

Antoni van Leeuwenhoek Hospital, Amsterdam

3584 CX

University Medical Center Utrecht, Utrecht

All Listed Sponsors

lead

The Netherlands Cancer Institute

OTHER

NCT04180033 - Diagnostic Yield of Colonoscopy Surveillance in Testicular Cancer Survivors Treated With Platinum-based Chemotherapy | Biotech Hunter | Biotech Hunter